XML 22 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:    
Net loss $ (2,189,042) $ (1,264,782)
Adjustments to reconcile net loss to net cash used by operating activities:    
Stock based compensation 143,673 17,114
Restricted stock expense 0 39,100
Issuance of stock / warrants for services 0 37,002
Amortization of debt issue costs 0 0
Depreciation and amortization 64,414 61,067
Gain on settlement of note (20,000) 0
Unrealized loss on marketable securities 1,553,303 0
Realized loss on sale of marketable securities 25,673 0
Loss on sale of property and equipment 0 69,511
Non-cash consideration received for services provided (407,500) (454,503)
Changes in operating assets and liabilities:    
Accounts receivable (113,629) 75,734
Accounts receivable - related party 204,902 712,325
Other accounts receivable (8,865) (37,612)
Other accounts receivable - related party 0 (54,545)
Note receivable (6,000) 0
Note receivable - related party 156,147 8,002
Merchant reserve (25,090) 0
Inventory (13,833) (4,952)
Prepaid expenses and other current assets 184,300 (221,545)
Marketable securities 174,327 0
Accounts payable and accrued expenses (329,680) 162,142
Accounts payable and accrued expenses - related party (308,627) (939,685)
Deferred revenue / customer deposits (114,375) 7,708
Deferred tax liability (133,000) (33,000)
Cash used by operating activities (1,162,902) (1,820,919)
Cash flows from investing activities:    
Net cash used for merger (1,177,669) 0
Purchase of investment other securities 0 (300,000)
Purchase of intangible assets (79,999) 0
Purchase of property and equipment (9,925) (2,665)
Cash used by investing activities (1,267,593) (302,665)
Cash flows from financing activities:    
Proceeds from issuance of common stock 6,356,997 10,927,535
Deferred issuance costs (177,521) (270,341)
Cash provided by financing activities 6,179,476 10,657,194
Net increase (decrease) in cash 3,748,981 8,533,610
Cash and cash equivalents, beginning of period 4,282,553 284,246
Cash and cash equivalents, beginning of period 8,031,534 8,817,856
Cash Payments for:    
Interest expense 203 259
Non-cash financial activities:    
Warrants issued to secondary selling agent 86,092 171,600
IPO costs incurred but unpaid as of quarter end 0 14,745
Stock received for prior period services, adjusted for other accounts receivable writedown prior to receipt $ 1,352,000 $ 0